1. | LisaLiving | |
2. | jesacoyote77 | |
3. | bensynergy | |
4. | nekketsukuniokun |
1. | LisaLiving | |
2. | jesacoyote77 | |
3. | bensynergy | |
4. | nekketsukuniokun |
1. | jesacoyote77 06/18/2018 FDA Hold, ouch |
2. | jesacoyote77 06/04/2018 Ziopharm Oncology Presents Clinical Data Demonstrating Anti-tumor Immune Response of Controlled IL-12 Platform in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual |
3. | bensynergy 10/02/2017 Phase 1/2 still beat all existing approved SOC options for recurrent GBM! |
4. | jesacoyote77 06/18/2018 Sold all today. Stay away from FDA holds! |
5. | LisaLiving 06/18/2018 This one is getting tricky going up or not |
6. | LisaLiving 09/29/2017 Quart was good |
7. | LisaLiving 10/02/2017 Stuck in a range |
8. | LisaLiving 01/22/2018 Big boost due to Juno |
9. | LisaLiving 03/05/2018 Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update |